CLINICAL_TRIALS
trial_result
· 2019-12-02
Clinical Trial Update: Study of Oral Lasmiditan in Participants With Normal and Impaired Renal Function [Phase 1]
Summary
Phase 1 study assessing oral lasmiditan in participants with normal and impaired renal function; completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Migraine | Phase 1 | Status: COMPLETED | Results posted: 2019-12-02